|Journal Name||Frontiers in Oncology|
|Journal Start Year||2011|
|Sub Subject||Ocular Oncology|
|Publisher||Frontiers Research Foundation|
|Journal Details||Journal Website|
Frontiers in Oncology publishes rigorously peer-reviewed research advancing our knowledge of cancer epidemiology, molecular pathways, diagnosis and imaging, personalized therapeutics, and novel treatment and management strategies.
Field Chief Editor Giuseppe Giaccone at Weill Cornell Medicine, Cornell University is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific advancement and impactful discoveries in the field of oncology to researchers, academics, clinicians, and the public worldwide.
Frontiers in Oncology welcomes contributions in the various domains of cancer research, from basic research to clinical studies. The journal is composed of different speciality sections and authors are kindly requested to consider the specific requirements of the most adequate speciality for their submission.
Most notably, manuscripts consisting solely of bioinformatics, computational analysis, or predictions of public databases which are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) will not be accepted in any of the sections of Frontiers in Oncology.
Frontiers in Oncology is a member of the Committee on Publication Ethics.
An abbreviation is a shortened form of a word or phrase, by any method. It may consist of a group of letters or words taken from the full version of the word or phrase.
The ISO4 Abbreviation of Frontiers in Oncology is Front Oncol.
An International Standard Serial Number is an eight-digit serial number used to uniquely identify a serial publication, such as a magazine. The ISSN is especially helpful in distinguishing between serials with the same title
"Frontiers in Oncology" Journal , and Online ISSN (eISSN) : 2234-943X
|Frontiers in Oncology eISSN :||2234-943X|
The University Grants Commission of India (UGC India) is the primary regulatory body created by the Indian Government in accordance with the UGC Act of 1956 under the Ministry of Human Resource Development. It has been made responsible for the coordination of Indian Universities, determination of the standards for Indian universities and maintenance of standards of higher education in India.
Yes Frontiers in Oncology is Indexed By UGC Care. you also can visit in UGC care list, may be they have updated their list. get a list of ugc approved journals.
PubMed is a free search engine accessing primarily the MEDLINE database of references and abstracts on life sciences and biomedical topics. The United States National Library of Medicine at the National Institutes of Health maintain the database as part of the Entrez system of information retrieval.
Yes the Frontiers in Oncology is PUBMED Indexed Journal.
|Frontiers in Oncology PUBMED Indexed Journal :|
Peer review means that a board of scholarly reviewers in the domain of the journal, review materials they publish for quality of research and adherence to editorial standards of the journal, before articles are accepted for publication.
It’s the ultimate litmus test for scientists and researchers to verify their findings.
When an article on an experiment and its hypothesis is submitted to a scholarly journal for publishing then it is meticulously tested.
If a journal makes an article goes through the process of ‘peer-review’ before being published then it is a peer-review journal.
Yes Frontiers in Oncology is Peer-Reviewed Journal and Published by Frontiers Research Foundation.
The Impact factor is also known by the name of journal impact factor of an academic journal. It is based on the scientometric index that shows the annual average number of citations. Moreover, impact factor is having all the information which is published in the last two years in the given journal received.
What is a good impact factor?
Before moving forward, it is essential to know about the necessary information about the impact factor. The definition of impact factor is the number of citations, the articles published in that journal during the last two preceding years, in the given year and divide this by the total number of citable items, which published in that journal in the previous two years.
On the other hand, along with the impact factor, it is important to know about the functional impact factor. Well, we all know that watch the numbers and higher will win. But the impact factor works beyond this and shows that numbers are not absolute. In other words, we can say that the higher the impact factor, the higher the rank of a journal.
The Frontiers in Oncology Impact factor is 6.244 (2023) Impact factor .
|Frontiers in Oncology Impact Factor :||6.244 (2023)|
|Note : This information is taken from the Journal Citation Reports™ (Clarivate).|
|Frontiers in Oncology Updated Impact Factor List|
Visit for all Journals Impact factor List